CD86 and neoplasm: The tumor-infiltrating cDC1 and cDC2 displayed a migratory and activated phenotype shown by CD40 and CCR7 expression, the RNA-seq data revealed overall upregulation of Cd40, Cd86 but also the cytokine Il12 in BRAFi-sensitive tumors.